Get the Stockscreener App
121.11
0.86%
1.03
After Hours:
120.93
-0.18
-0.15%
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $121.11, with a volume of 2.73M.
It is up +0.86% in the last 24 hours and up +4.75% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$120.08
Open:
$119.61
24h Volume:
2.73M
Relative Volume:
0.65
Market Cap:
$50.93B
Revenue:
$9.47B
Net Income/Loss:
$2.67B
P/E Ratio:
20.11
EPS:
6.0218
Net Cash Flow:
$2.28B
1W Performance:
+3.69%
1M Performance:
+4.75%
6M Performance:
-15.58%
1Y Performance:
-19.70%
1-Day Range:
$118.60
$121.54
1-Week Range:
$116.85
$121.54
52-Week Range:
$113.29
$172.23
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis (ZTS) EVP Julie Fuller granted cash-settled phantom units - Stock Titan
Zoetis (ZTS) EVP Roxanne Lagano receives 550 phantom stock units - Stock Titan
Zoetis (ZTS) EVP receives new phantom stock unit award - Stock Titan
[Form 4] Zoetis Inc. Insider Trading Activity - Stock Titan
Zoetis (NYSE: ZTS) CEO granted 2,776 phantom stock units in savings plan - Stock Titan
Zoetis (ZTS) EVP Rimma Driscoll receives new phantom stock unit grant - Stock Titan
Zoetis (NYSE: ZTS) CFO receives cash-settled phantom stock award - Stock Titan
Zoetis (ZTS) EVP Keith Sarbaugh receives new phantom stock unit grant - Stock Titan
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
VIX Spike: How does Zoetis Inc correlate with NasdaqEarnings Performance Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Technical Analysis: Will Zoetis Inc benefit from rate cutsQuarterly Trade Review & Target Return Focused Picks - baoquankhu1.vn
How Zoetis Inc. Class A (ZTS) Affects Rotational Strategy Timing - Stock Traders Daily
Wall Street Analysts See a 28.23% Upside in Zoetis (ZTS): Can the Stock Really Move This High? - Zacks Investment Research
Watch Zoetis CEO: AI Boosts 'Resilient' Animal Health Business - Bloomberg.com
Blue Zone Wealth Advisors, LLC's Zoetis Inc(ZTS) Holding History - GuruFocus
Zoetis Inc (LIM:ZTS)Valuation Measures & Financial Statistics - GuruFocus
Zoetis Inc (LIM:ZTS) Competitors 2026 - GuruFocus
Zoetis Inc Stock Operating Data - GuruFocus
Zoetis Inc (LIM:ZTS) Dividend - GuruFocus
Zoetis Inc (LIM:ZTS) Stock Price & 30 Year Financial Data - GuruFocus
Who's Buying or Selling Zoetis Inc (LIM:ZTS) Stock Today? - GuruFocus
Zoetis Inc (LIM:ZTS) Valuation - GuruFocus
Zoetis (LIM:ZTS) Short-Term Capital Lease Obligation : $0 Mil (As of Dec. 2025) - GuruFocus
Zoetis Inc (LIM:ZTS) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Zoetis (LIM:ZTS) Sale Of Property, Plant, Equipment : $0 Mil (TTM As of Dec. 2025) - GuruFocus
Zoetis Inc (LIM:ZTS) Stock News, Headlines & Updates - GuruFocus
Zoetis Inc (LIM:ZTS) Stock Price, Trades & News - GuruFocus
Zoetis Inc (XBUL:ZOE) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
How Zoetis’ Activist Clash Over Written-Consent Rights At Zoetis (ZTS) Has Changed Its Investment Story - simplywall.st
Zoetis (ZTS) Declines More Than Market: Some Information for Investors - Yahoo Finance
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis Inc (XSWX:ZTS) Stock Price, Trades & News - GuruFocus
Here's Why Zoetis (ZTS) is a Strong Momentum Stock - Yahoo Finance
Berkeley, Inc's Zoetis Inc(ZTS) Holding History - GuruFocus
Zoetis Inc. (ZTS) Stock Forecasts - Yahoo Finance
Why Zoetis (ZTS) is a top value stock for the long term - MSN
Zoetis Inc. (ZOE.F) stock price, news, quote and history - Yahoo Finance UK
Zoetis Inc SEC Filings - Stock Titan
Buybacks Report: Will Zoetis Inc stock hit new highs in YEAREarnings Overview Report & Daily Entry Point Alerts - baoquankhu1.vn
Zoetis Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
John Chevedden Submits Shareholder Proposal to Zoetis - marketscreener.com
How Investors May Respond To Zoetis (ZTS) Deepening Its Biologics Focus After World Vaccine Congress Update - Yahoo Finance
Will Zoetis (ZTS) Surpass Expectations in Its Upcoming Earnings Announcement? - Bitget
WILSON ASSET MANAGEMENT (INTERNATIONAL) PTY LTD's Zoetis Inc(ZTS) Holding History - GuruFocus
Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Zoetis (ZTS) Q4 2024 Earnings Call Transcript - The Globe and Mail
[ARS] Zoetis Inc. SEC Filing - Stock Titan
Zoetis (NYSE: ZTS) sets 2026 votes on directors, pay and consent - Stock Titan
Minneapolis Portfolio Management Group, LLC's Zoetis Inc(ZTS) Holding History - GuruFocus
BofA Securities Maintains Zoetis(ZTS.US) With Hold Rating, Maintains Target Price $140 - Moomoo
Zoetis Equine Renews Title Sponsorship for the 2026 Horses for Mental Health Campaign - The Plaid Horse Magazine
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):